Long-term effectiveness and safety of ustekinumab in patients with Crohn' s disease: real-world evidence
{{output}}
Background: Ustekinumab (UST) is an interleukin-12/interleukin-23 receptor antagonist approved for the treatment of Crohn's disease (CD). Although UST has demonstrated good efficacy and safety in CD, long-term real-world data in... ...
